For Healthcare Professionals

Paclitaxel-coated Peripheral Stents Used in the Treatment of Femoropopliteal Stenoses

clipboard-pencil

About the study

This randomized multi-center study is intended to compare different coatings on stents for treatment of lesions of the above-the-knee femoropopliteal artery.
user-3

Who can take part

You may be eligible to participate in the study if you meet the following criteria:

INCLUSION CRITERIA

Inclusion Criteria:


  1. One de novo or restenosed artherosclerotic lesion with ≥ 50% diameter stenosis
  2. Symptoms of peripheral arterial disease (Rutherford 2-4)

EXCLUSION CRITERIA

Exclusion Criteria:


  1. Pregnant, breastfeeding, or planning to become pregnant in the next 5 years
  2. Less than 18 years old
  3. Medical condition or disorder that would limit life expectancy to less than 12 months or that may cause noncompliance with the protocol or confound the data analysis
  4. Previous stent in the study vessel

pin location

Study Locations

Enter your ZIP code/Postal code/PIN code to locate study sites near you:

How to Apply


Contact the study center to learn if this study is a good match for you.

Study’s details


Contition

Peripheral Arterial Disease (PAD)

Age (in years)

18+

Phase

Not Applicable

Participants needed

176

Est. Completion Date

Jan 31, 2024

Treatment type

Interventional


Sponsor

Cook Group Incorporated

ClinicalTrials.gov identifier

NCT02936622

Study number

13-002

Understanding Clinical Trials


Get answers to your questions about clinical trials.What is a clinical research?What does taking part in clinical trials involve?What should I ask the trial doctor?
Vector

Interested?

Sign up to save your favorites, 
receive newsletters, resources, and alerts 
about clinical trials related to your conditions of interest.